Cargando…
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts
Resistance to androgen deprivation therapies leads to metastatic castration-resistant prostate cancer (mCRPC) of adenocarcinoma (AdCa) origin that can transform to emergent aggressive variant prostate cancer (AVPC) which has neuroendocrine (NE)-like features. To this end, we used LuCaP patient-deriv...
Autores principales: | Sychev, Zoi E., Day, Abderrahman, Bergom, Hannah E., Larson, Gabrianne, Ali, Atef, Ludwig, Megan, Boytim, Ella, Coleman, Ilsa, Corey, Eva, Plymate, Stephen R., Nelson, Peter S., Hwang, Justin H., Drake, Justin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418188/ https://www.ncbi.nlm.nih.gov/pubmed/37577653 http://dx.doi.org/10.1101/2023.08.02.551697 |
Ejemplares similares
-
ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
por: Bae, Song Yi, et al.
Publicado: (2023) -
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer
por: Shi, Xiaolei, et al.
Publicado: (2022) -
ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems
por: Bergom, Hannah E., et al.
Publicado: (2023) -
Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023) -
Sperm Phosphoproteome: Unraveling Male Infertility
por: Serrano, Rebeca, et al.
Publicado: (2022)